Montana Medical Association Prescription Drug Abuse Prevention Training- with 7.5 AMA PRA Catagory 1 Credits
Prescription drug abuse and diversion is a growing epidemic in Montana, contributing to the deaths of more than 300 Montanans each year. The Montana Medical Association and its partners designed this four module course to help health care teams find the proper balance between providing appropriate treatment for patients while protecting them from opioid addiction.
This series provides valuable information for physicians and non-physicians who are involved in patient care concerning opioid medications. Physicians are encouraged to include all appropriate members of their teams in this training. The program addresses the problem on a state and national level, how to prescribe opioids and how to communicate with patients about the dangers of prescription drugs. Non-physicians who complete the webinar and a post-webinar evaluation will also receive a certificate of completion.
Date of Original Release: 7/30/2015
Date of Most Recent Review: 7/30/2019
Termination Date: December 31, 2022
Course Intended For All Specialties: Physicians, Dentists, Physician's Assistants, Pharmacists, Nurses, Nurse Practitioners, Advanced Practice Nurses
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and Montana Medical Association. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: The Colorado Medical Society designates this enduring material for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures: Speakers: Greg Holzman, MD, Tony King, PharmD, Bryan Lockerby, Marc Mentel, DO, Daniel Nauts, MD, Robert Sherrick, MD, Scott Stayner, MD, and David Young, DVM report having no actual or potential conflict of interest in relation to this educational activity.
Planners and other Administrative Support:
Alex Esber, Nina Aiviar, Scot Drake, Elvis Funes, David Sabbath, and Shannon V Simon report having no actual or potential conflict of interest in relation to this educational activity.
Upon conclusion of this activity, participants should be able to:
1. Implement recommended prescribing practices and alternate forms of treatment for patients presenting with acute or chronic pain.
2 Use the toolkit and resources to manage patient treatment
3. Apply the state and federal laws as related to prescribing Schedule II drugs
4. Examine the prescription drug issue from a state and national level
5. Know the medications used for the treatment of addiction and withdrawal according to DEA regulations and know the disease model of OUD and the importance of identifying and treating it in office, ER and inpatient settings
6. Implement the use of Medication Assisted Treatment as the standard of care for opioid use disorder, the medications used in MAT and the role of counseling in MAT
7. Define harm reduction and outcome directed treatment and the concept levels of care of MAT
Dr. Camden Kneeland has reported that he is a clinical researcher for spinal cord stimulation for St. Jude Medical. All others in control of the content of this activity have reported no relevant financial relationships with commercial interests.